D

$DASTY

6 articles found
4 positive
0 negative
2 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Dassault Systèmes Proposes €0.27 Dividend as AI Strategy Drives Growth

Dassault Systèmes proposes €0.27 per share dividend for 2025, emphasizing AI-native industrial platform strategy and sustainable profitable growth.
DASTYinfrastructureartificial intelligence
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Dassault Systèmes Proposes €0.27 Dividend as AI Strategy Drives Growth

Dassault Systèmes proposes €0.27 per share dividend for 2025, underscoring confidence in AI strategy and digital twin technology growth across manufacturing and life sciences sectors.
DASTYartificial intelligencedividend announcement
GlobeNewswire Inc.GlobeNewswire Inc.··Dassault Systèmes

Dassault Systèmes Discloses Share Count and Voting Rights Ahead of Spring Shareholder Season

Dassault Systèmes reports 1.34 billion outstanding shares and 2.01 billion voting rights as of February 28, 2026, in regulatory compliance.
DASTYregulatory compliancevoting rights
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Dassault Systèmes Reports Share Capital, Voting Rights in Regulatory Filing

Dassault Systèmes disclosed 1.34 billion outstanding shares and 2.01 billion total voting rights as of February 28, 2026, reflecting its dual-class share structure.
DASTYregulatory compliancevoting rights
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Medidata Earns Top 'Luminary' AI Rating as Solutions Back 80% of FDA Drug Approvals

Medidata secures top 'Luminary' AI rating from Everest Group, supporting 80% of FDA approvals with up to 37% faster patient enrollment.
DASTYagentic AIclinical development
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Healthcare Digital Twins Market Poised for 31-Fold Growth to Nearly $70B by 2035

Healthcare digital twins market expected to surge from $2.22B in 2025 to $69.67B by 2035, driven by AI integration and precision medicine adoption.
NVDAMSFTIBMPHGDASTY+1precision medicinemedical devices